<?xml version="1.0" encoding="UTF-8"?>
<p>The replication cycle of coronavirus or the virus‐infected host cells possesses several virus‐specific processes or protein molecules that could be targeted for effective antiviral drug design. An effective antiviral agent might halt the viral progression in the infected cell without being allergic or toxic to surrounding noninfected cells (Zhu, Meng, Wang, &amp; Wang, 
 <xref rid="ddr21709-bib-0203" ref-type="ref">2015</xref>).
</p>
